This HTML5 document contains 36 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n14http://linked.opendata.cz/resource/drugbank/drug/DB08066/identifier/chemspider/
n13http://bio2rdf.org/drugbank:
n11http://linked.opendata.cz/resource/drugbank/drug/DB08066/identifier/pdb/
admshttp://www.w3.org/ns/adms#
n4http://linked.opendata.cz/resource/drugbank/drug/DB08066/identifier/pubchem-compound/
n9http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
n7http://linked.opendata.cz/resource/drugbank/drug/DB08066/identifier/pubchem-substance/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n5http://linked.opendata.cz/ontology/drugbank/
n10http://linked.opendata.cz/resource/drugbank/drug/DB08066/identifier/drugbank/
n6http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#

Statements

Subject Item
n2:DB08066
rdf:type
n5:Drug
n5:group
experimental
owl:sameAs
n9:DB08066 n13:DB08066
dcterms:title
N-[3-(1H-BENZIMIDAZOL-2-YL)-1H-PYRAZOL-4-YL]BENZAMIDE
adms:identifier
n4:25138278 n7:99444537 n10:DB08066 n11:L0H n14:24720248
n5:IUPAC-Name
n6:271B5ABA-363D-11E5-9242-09173F13E4C5
n5:InChI
n6:271B5AC0-363D-11E5-9242-09173F13E4C5
n5:Molecular-Formula
n6:271B5ABF-363D-11E5-9242-09173F13E4C5
n5:Molecular-Weight
n6:271B5ABC-363D-11E5-9242-09173F13E4C5
n5:Monoisotopic-Weight
n6:271B5ABD-363D-11E5-9242-09173F13E4C5
n5:SMILES
n6:271B5ABE-363D-11E5-9242-09173F13E4C5
n5:Water-Solubility
n6:271B5AB8-363D-11E5-9242-09173F13E4C5
n5:logP
n6:271B5AB9-363D-11E5-9242-09173F13E4C5 n6:271B5AB6-363D-11E5-9242-09173F13E4C5
n5:logS
n6:271B5AB7-363D-11E5-9242-09173F13E4C5
n5:H-Bond-Acceptor-Count
n6:271B5AC6-363D-11E5-9242-09173F13E4C5
n5:H-Bond-Donor-Count
n6:271B5AC7-363D-11E5-9242-09173F13E4C5
n5:InChIKey
n6:271B5AC1-363D-11E5-9242-09173F13E4C5
n5:Polar-Surface-Area--PSA-
n6:271B5AC2-363D-11E5-9242-09173F13E4C5
n5:Polarizability
n6:271B5AC4-363D-11E5-9242-09173F13E4C5
n5:Refractivity
n6:271B5AC3-363D-11E5-9242-09173F13E4C5
n5:Rotatable-Bond-Count
n6:271B5AC5-363D-11E5-9242-09173F13E4C5
n5:Bioavailability
n6:271B5ACC-363D-11E5-9242-09173F13E4C5
n5:Ghose-Filter
n6:271B5ACE-363D-11E5-9242-09173F13E4C5
n5:MDDR-Like-Rule
n6:271B5ACF-363D-11E5-9242-09173F13E4C5
n5:Number-of-Rings
n6:271B5ACB-363D-11E5-9242-09173F13E4C5
n5:Physiological-Charge
n6:271B5ACA-363D-11E5-9242-09173F13E4C5
n5:Rule-of-Five
n6:271B5ACD-363D-11E5-9242-09173F13E4C5
n5:Traditional-IUPAC-Name
n6:271B5ABB-363D-11E5-9242-09173F13E4C5
n5:pKa--strongest-acidic-
n6:271B5AC8-363D-11E5-9242-09173F13E4C5
n5:pKa--strongest-basic-
n6:271B5AC9-363D-11E5-9242-09173F13E4C5